218 related articles for article (PubMed ID: 16616907)
21. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism.
Elfarra AA; Krause RJ; Kemper RA
Chem Biol Interact; 2001 Jun; 135-136():239-48. PubMed ID: 11397394
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.
Georgieva NI; Boysen G; Upton PB; Jayaraj K; Gold A; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):219-25. PubMed ID: 16860298
[TBL] [Abstract][Full Text] [Related]
23. Cob(I)alamin for trapping butadiene epoxides in metabolism with rat S9 and for determining associated kinetic parameters.
Motwani HV; Fred C; Haglund J; Golding BT; Törnqvist M
Chem Res Toxicol; 2009 Sep; 22(9):1509-16. PubMed ID: 19764821
[TBL] [Abstract][Full Text] [Related]
24. Bis-butanediol-mercapturic acid (bis-BDMA) as a urinary biomarker of metabolic activation of butadiene to its ultimate carcinogenic species.
Kotapati S; Sangaraju D; Esades A; Hallberg L; Walker VE; Swenberg JA; Tretyakova NY
Carcinogenesis; 2014 Jun; 35(6):1371-8. PubMed ID: 24531806
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
27. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
28. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
29. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
30. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
[TBL] [Abstract][Full Text] [Related]
31. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
32. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
33. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
34. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
[TBL] [Abstract][Full Text] [Related]
35. 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.
Kirman CR; Albertini RJ; Sweeney LM; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():1-11. PubMed ID: 20868266
[TBL] [Abstract][Full Text] [Related]
36. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
Boogaard PJ; de Kloe KP; Booth ED; Watson WP
Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
[TBL] [Abstract][Full Text] [Related]
37. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
Sweeney LM; Himmelstein MW; Gargas ML
Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398
[TBL] [Abstract][Full Text] [Related]
38. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry.
Tretyakova NYu ; Chiang SY; Walker VE; Swenberg JA
J Mass Spectrom; 1998 Apr; 33(4):363-76. PubMed ID: 9597770
[TBL] [Abstract][Full Text] [Related]
40. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
